Company profile: Lightpoint Medical
1.1 - Company Overview
Company description
- Provider of intraoperative imaging technology for real-time cancer detection during surgery, including Cerenkov Luminescence Imaging (CLI) to reduce recurrence and reoperation; offers SENSEI®, a miniature gamma probe for minimally-invasive and robot-assisted procedures to detect radiation and guide surgeons.
Products and services
- Cerenkov Luminescence Imaging (CLI): Develops an intraoperative imaging system with real-time cancer detection potential during surgery, intended to reduce recurrence and reoperation
- Intraoperative-grade
- SENSEI: Offers a miniature gamma probe for minimally-invasive and robot-assisted surgeries, detecting radiation and guiding surgeons in real time for precise intraoperative cancer localization
- Miniature-scale
- Intra-operative Imaging R&D: Develops medical-device technology that can detect cancer during surgery, advancing intraoperative imaging for cancer surgery
- Medical-device
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Lightpoint Medical
Phanes Therapeutics
HQ: United States
Website
- Description: Provider of therapeutics for solid tumors and eye diseases, offering PACbody, ATACCbody, and SPECpair platforms for native IgG-like and conjugated bispecific antibodies compatible with conventional monoclonal manufacturing, and a Phase 1 pipeline including PT199 (NSCLC, PDAC), PT886 (metastatic/advanced gastric, gastroesophageal junction, pancreatic adenocarcinoma), and PT217 (advanced refractory DLL3-expressing cancers).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Phanes Therapeutics company profile →
Galecto
HQ: Denmark
Website
- Description: Provider of clinical-stage small molecule therapies for fibrosis and cancer. Develops inhibitors including GB0139, an inhaled galectin-3 inhibitor for severe fibrotic lung diseases such as idiopathic pulmonary fibrosis; GB1211, an oral galectin-3 inhibitor for decompensated cirrhosis; and GB2064, a LOXL2 inhibitor for myelofibrosis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Galecto company profile →
Avacta
HQ: United Kingdom
Website
- Description: Provider of technologies, consumables and reagents for life science markets from drug discovery to diagnostics; engaged in research, development, production and delivery of instrumentation and services for biopharmaceutical drug development and clinical diagnostics using biophysical technology. Offerings include the pre|CISION Platform, Affimer Technology, AVA6000, Launch Diagnostics (UK/France), and Coris Bioconcept rapid diagnostic test kits.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Avacta company profile →
Lava Therapeutics
HQ: The Netherlands
Website
- Description: Provider of a bispecific antibody platform engaging gamma-delta (Vγ9Vδ2) T cells for treatment of hematological and solid cancers. Offers the Gammabody® platform to generate T cell engagers targeting tumor-associated antigens, and drug candidates LAVA-051 for hematologic malignancies and solid tumors, and LAVA-1207 for metastatic castration-resistant prostate cancer.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lava Therapeutics company profile →
RITA Medical Systems
HQ: United States
Website
- Description: Provider of innovative tumor ablation products, developing, manufacturing and marketing the proprietary RITA system, which uses radiofrequency energy to heat tissue to ablate it or cause cell death, with a current focus on liver cancer and metastatic bone cancer.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full RITA Medical Systems company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Lightpoint Medical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Lightpoint Medical
2.2 - Growth funds investing in similar companies to Lightpoint Medical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Lightpoint Medical
4.2 - Public trading comparable groups for Lightpoint Medical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →